| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $451K | +37.0% |
| SG&A Expense | $11.2M | -2.7% |
| Operating Income | -$11.7M | -10.5% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$10.5M | -1.2% |
| Income Tax | $51K | -69.0% |
| Net Income | -$3.3M | -21.5% |
| EPS (Diluted) | -$0.53 | -17.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.0M | -33.8% |
| Accounts Receivable | $226K | — |
| Current Assets | $20.2M | -31.0% |
| Total Assets | $23.6M | -26.2% |
| Current Liabilities | $2.8M | +14.3% |
| Total Liabilities | $2.9M | -6.8% |
| Stockholders' Equity | $20.7M | -28.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.9M | +2.6% |
| Capital Expenditures | $2.5M | +4252.0% |
| Investing Cash Flow | -$855K | -1359.2% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$11.4M | -24.6% |